SCHEMBL6590170

SCHEMBL6590170

CN1CCC(N(C)Cc2csc(C(=O)Nc3c(C(=O)Nc4ccc(Cl)cn4)cc(Cl)cc3N(C)C)c2Cl)CC1

nearest known ligand 0.63

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
F2 P00734 20/20 0.63
F10 P00742 18/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6589701 0.92 F2 (0.64) F2F10
SCHEMBL6588941 0.89 F2 (0.66) F2F10
SCHEMBL6590341 0.88 F2 (0.59) F2F10
SCHEMBL6593127 0.87 F2 (0.79) F2F10
SCHEMBL27453704 0.85 F2 (0.58) F2F10
SCHEMBL6588942 0.85 F2 (0.64) F2F10
SCHEMBL6593541 0.84 F2 (0.74) F2F10
SCHEMBL6594350 0.84 F2 (0.65) F2F10
SCHEMBL6588467 0.83 F2 (0.82) F2F10
SCHEMBL6588619 0.82 F2 (0.74) F2F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1040108-B1 ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS SCHERING AG (DE) 2004-02-25 EP claimed
EP-1040108-B1 ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS SCHERING AG (DE) 2004-02-25 EP disclosed
US-6498185-B1 ENZYME FACTOR XA INHIBITORS BERLEX LABORATORIES, INC. 2002-12-24 US disclosed
US-6380221-B1 FOR THERAPY OF DISEASE-STATES CHARACTERIZED BY THROMBOTIC ACTIVITY BERLEX LABORATORIES, INC. 2002-04-30 US disclosed
US-6140351-A FOR TREATING THROMBOSIS BERLEX LABORATORIES, INC. (US) 2000-10-31 US disclosed